India, June 1 -- As the Ebola outbreak is getting bigger every day, the problem for health workers continues to surge. At this time, when there are more than 900 suspected cases and over 220 suspected deaths, the world is searching for the answer, and finally, something meaningful is happening. Biotechnology giant Moderna announced on Monday that it is partnering with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a potential vaccine against Bundibugyo ebolavirus (BDBV), the strain responsible for the current outbreak.

To prevent the Ebola outbreak, this partnership will play a vital role. With the help of this agreement, CEBI has pledged up to $50 million to support the preclinical development and early-stage clin...